← Back to Search

Diagnostic Test

MeMed BV Test for Respiratory Infection

N/A
Recruiting
Research Sponsored by MeMed Diagnostics Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 18 months
Awards & highlights

Study Summary

This trial will study how a test can help clinicians decide whether to prescribe antibiotics to patients with LRTI. It aims to improve medical care and health outcomes.

Who is the study for?
Adults over 18 with symptoms of lower respiratory tract infections (LRTI) such as cough or chest discomfort, who haven't taken antibiotics in the last 72 hours. Participants must have a fever and be suspected to need antibiotics. Excluded are those with recent major trauma, active cancer, certain immune conditions, recent surgery, or known HIV/HBV/HCV.Check my eligibility
What is being tested?
The trial is testing the MeMed BV test's effectiveness in guiding antibiotic use for patients with LRTI in emergency and urgent care settings. It aims to see if this can improve patient outcomes and reduce unnecessary antibiotic prescriptions.See study design
What are the potential side effects?
Since the intervention is a diagnostic test rather than a medication or therapy, there are no direct side effects from the MeMed BV test itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To demonstrate MeMed BV® added value on top of standard of care in lowering unwarranted antibiotic prescribing in patients with LRTI in the ED/UCC.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Adults with suspected Lower Respiratory Track Infection (LRTI)- The MeMed BV armExperimental Treatment1 Intervention
ED and urgent care center patients over the age of 18 years , with clinical suspicion of Lower Respiratory Track Infection. clinician will receive the BV result, this will include a recommendation regarding antibiotic treatment. A telephone FU call will be done at 28 (+/- 3) days after the day of consent to complete a short questionnaire regarding your current illness
Group II: Adults with suspected Lower Respiratory Track Infection (LRTI)- The control armActive Control1 Intervention
ED and urgent care center patients over the age of 18 years , with clinical suspicion of Lower Respiratory Track Infection. clinician will not receive the BV result, and will treat according to standard of care. A telephone FU call will be done at 28 (+/- 3) days after the day of consent to complete a short questionnaire regarding your current illness

Find a Location

Who is running the clinical trial?

MeMed Diagnostics Ltd.Lead Sponsor
14 Previous Clinical Trials
10,956 Total Patients Enrolled
1 Trials studying Bronchitis
583 Patients Enrolled for Bronchitis

Media Library

MeMed BV test (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT05762302 — N/A
Bronchitis Research Study Groups: Adults with suspected Lower Respiratory Track Infection (LRTI)- The MeMed BV arm, Adults with suspected Lower Respiratory Track Infection (LRTI)- The control arm
Bronchitis Clinical Trial 2023: MeMed BV test Highlights & Side Effects. Trial Name: NCT05762302 — N/A
MeMed BV test (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05762302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age eligibility for this research restricted to individuals under 25 years old?

"Within the parameters of this investigation, geriatric individuals aged 18 and above up to 99 years old are eligible for participation."

Answered by AI

Are there any vacancies in this experiment for volunteers?

"According to clinicaltrials.gov, this specific trial has concluded recruitment and is not seeking any further patients. It was initially listed on March 1st 2023 before being last edited two days later. Fortunately, there are currently 992 other trials actively enrolling volunteers across the world."

Answered by AI

Who has the authority to take part in this research?

"This study is recruiting up to 1316 participants that have bronchitis and are between the ages of 18 and 99."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
2023. "The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05762302.
~607 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top